NCT07076979View on ClinicalTrials.gov

Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

June 15, 2025

Primary Completion Date

July 1, 2028

Study Completion Date

July 1, 2030

Conditions
Gastric Cancer
Trial Locations (1)

Unknown

RECRUITING

Ruijin hospital Shanghai Jiaotong University, School of Medicine , Shanghai, Shanghai 200025, Shanghai

All Listed Sponsors
lead

Shanghai Minimally Invasive Surgery Center

OTHER

NCT07076979 - Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC | Biotech Hunter | Biotech Hunter